AY

Aaliya Younus Naik

Active Director Director DIN 10162136
DIN 10162136 First appointment May 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value •••• Premium profile

About Aaliya Younus Naik

Data last updated:

Aaliya Younus Naik is a Director at Aspan Pharma Private Limited (since 2023). The company operates in Paper. Aspan Pharma Private Limited reported revenue of ₹2.04 Cr (FY 2025).

DIN 10162136
Primary Designation Director
Industry Paper
First Appointment 13 May 2023
Oldest Company Age 3 yrs
Largest company Aspan Pharma Private Limited · ₹2.04 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aspan Pharma Private Limited U21001MH2023PTC402890
Director13 May 20232023₹2.04 Cr (FY 2025)Active

Board colleagues of Aaliya Younus Naik

NameDINCompanyDesignation
Ashutosh Suresh Gokhale00344378Aspan Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aspan Pharma Private Limited
Premium access

Shareholding and investment profile for Aaliya Younus Naik

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aaliya Younus Naik

Aaliya Younus Naik currently holds 1 directorship: Aspan Pharma Private Limited (Director, since 13 May 2023, revenue ₹2.04 Cr (FY 2025)).

Aaliya Younus Naik was first appointed on 13 May 2023 as Director at Aspan Pharma Private Limited.

The current boards of Aaliya Younus Naik's companies include Ashutosh Suresh Gokhale (Aspan Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available